Genzyme, which is a world leader in biotechnology, is creating a new polyclonal antibody production site. This is an innovative production facility: The process has been automated as far as possible, to reduce human error in the many stages of the process (separation, purification, filtration, ultrafiltration, haemadsorption etc.) This involves being able to interface with a battery of very mixed laboratory equipment, which was not initially designed to communicate with fieldbuses.
Application Solution
Genzyeme has used about 30 HMS Anybus communicator gateways, to enable consistent SCADA management across all the devices in use. Read the full solution
Tri-Phase Automation is a distributor of HMS/Anybus in Wisconsin.
Contact Tri-Phase Sales or Get a Quote
A case study from HMS/Anybus
Genzyme, which is a world leader in biotechnology, is creating a new polyclonal antibody production site. This is an innovative production facility: The process has been automated as far as possible, to reduce human error in the many stages of the process (separation, purification, filtration, ultrafiltration, haemadsorption etc.) This involves being able to interface with a battery of very mixed laboratory equipment, which was not initially designed to communicate with fieldbuses.
Application Solution
Genzyeme has used about 30 HMS Anybus communicator gateways, to enable consistent SCADA management across all the devices in use.
Read the full solution
Tri-Phase Automation is a distributor of HMS/Anybus in Wisconsin.
Contact Tri-Phase Sales or Get a Quote
Recent Posts